Facetten
Zugriff
Einrichtung
Medientyp
- Text 7
Karte
Erscheinungsjahr
Autor/in
- Bissonnette, Robert
- Reich, Kristian 7
- Kabashima, Kenji 3
- Silverberg, Jonathan I 3
- Beck, Lisa A 2
- alle zeigen
Sprache
- Englisch 7
7 Einträge gefunden
-
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): a clinical outcome measure for the severity of atopic dermatitis
- Simpson, Eric L
- Bissonnette, Robert
- Paller, Amy S
- King, Brett
- Silverberg, Jonathan I
- Reich, Kristian
- Thyssen, Jacob P
-
Magnitude and Time Course of Response to Abrocitinib for Moderate-to-Severe Atopic Dermatitis
- Reich, Kristian
- Lio, Peter A
- Bissonnette, Robert
- Alexis, Andrew F
- Lebwohl, Mark G
- Pink, Andrew E
- Kabashima, Kenji
-
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical Trials
- Silverberg, Jonathan I
- Simpson, Eric L
- Wollenberg, Andreas
- Bissonnette, Robert
- Kabashima, Kenji
- DeLozier, Amy M
- Sun, Luna
-
Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study
- Mrowietz, Ulrich
- Burden, A David
- Pinter, Andreas
- Reich, Kristian
- Schäkel, Knut
- Baum, Patrick
- Datsenko, Yakov
-
Differential Changes in Inflammatory Mononuclear Phagocyte and T-Cell Profiles within Psoriatic Skin during Treatment with Guselkumab vs. Secukinumab
- Mehta, Heena
- Mashiko, Shunya
- Angsana, Julianty
- Rubio, Manuel
- Hsieh, Ya-Ching M
- Maari, Catherine
- Reich, Kristian
-
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis
- Simpson, Eric
- Bissonnette, Robert
- Eichenfield, Lawrence F
- Guttman-Yassky, Emma
- King, Brett
- Silverberg, Jonathan I
- Beck, Lisa A
-
Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study
- Deleuran, Mette
- Thaçi, Diamant
- Beck, Lisa A
- de Bruin-Weller, Marjolein
- Blauvelt, Andrew
- Forman, Seth
- Bissonnette, Robert